Single-Center Retrospective Subgroup Analysis of "Primary Aortic" (Aneurysm, Aortic Dissection, PAU) and "Secondary Aortic" (Iatrogenic, Trauma, Aortoesophageal Fistula) Indications for Emergency TEVAR.
TEVAR
aortic aneurysm
aortic dissection
aortic emergencies
aortoesophageal fistula
iatrogenic
trauma
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
13 Jun 2023
13 Jun 2023
Historique:
received:
22
04
2023
revised:
22
05
2023
accepted:
12
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
The aim of this study was to analyze the outcome of emergency thoracic endovascular aortic repair (TEVAR) in the treatment of "primary aortic" (aneurysm, aortic dissection, penetrating aortic ulcer (PAU)) and "secondary aortic" (iatrogenic, trauma, and aortoesophageal fistula) pathologies. Retrospective review of a cohort of patients treated at a single tertiary referral center from 2015 to 2021. The primary end point was postoperative in-hospital mortality. Secondary end points were the duration of the procedure, duration of postoperative intensive care treatment, length of hospital stay, and the nature and severity of postoperative complications according to the Dindo-Clavien classification. A total of 34 patients underwent TEVAR for emergency indications. Twenty-two patients were treated for primary and twelve patients for secondary aortic pathologies. Concerning in-hospital mortality, no statistically significant difference could be observed between the primary and secondary aortic groups (27.3% vs. 33.3%, Morbidity and in-hospital mortality are still considerable after emergency TEVAR for both primary and secondary aortic indications. Pre- and postoperative levels of hemoglobin, creatinine, and lactate may be valuable to predict patient outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of this study was to analyze the outcome of emergency thoracic endovascular aortic repair (TEVAR) in the treatment of "primary aortic" (aneurysm, aortic dissection, penetrating aortic ulcer (PAU)) and "secondary aortic" (iatrogenic, trauma, and aortoesophageal fistula) pathologies.
METHODS
METHODS
Retrospective review of a cohort of patients treated at a single tertiary referral center from 2015 to 2021. The primary end point was postoperative in-hospital mortality. Secondary end points were the duration of the procedure, duration of postoperative intensive care treatment, length of hospital stay, and the nature and severity of postoperative complications according to the Dindo-Clavien classification.
RESULTS
RESULTS
A total of 34 patients underwent TEVAR for emergency indications. Twenty-two patients were treated for primary and twelve patients for secondary aortic pathologies. Concerning in-hospital mortality, no statistically significant difference could be observed between the primary and secondary aortic groups (27.3% vs. 33.3%,
CONCLUSIONS
CONCLUSIONS
Morbidity and in-hospital mortality are still considerable after emergency TEVAR for both primary and secondary aortic indications. Pre- and postoperative levels of hemoglobin, creatinine, and lactate may be valuable to predict patient outcomes.
Identifiants
pubmed: 37373731
pii: jcm12124037
doi: 10.3390/jcm12124037
pmc: PMC10299706
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur J Cardiothorac Surg. 2009 Feb;35(2):282-6
pubmed: 19081731
Ann Vasc Surg. 2014 Oct;28(7):1782-8
pubmed: 24930979
J Endovasc Ther. 2009 Aug;16(4):428-40
pubmed: 19702348
Cochrane Database Syst Rev. 2019 Feb 06;2:CD006642
pubmed: 30723895
J Vasc Surg. 2008 Nov;48(5):1343-51
pubmed: 18632242
Esophagus. 2020 Jan;17(1):74-80
pubmed: 31587121
Ann Surg Oncol. 2021 Dec;28(13):8385-8386
pubmed: 34115249
J Vasc Surg. 2011 Jan;53(1):187-92
pubmed: 20974523
Ann Vasc Surg. 2016 Jan;30:307.e15-9
pubmed: 26520422
J Vasc Surg. 2016 May;63(5):1170-1181.e1
pubmed: 26921004
Cochrane Database Syst Rev. 2016 Apr 27;4:CD011738
pubmed: 27119426
Cochrane Database Syst Rev. 2021 Dec 14;12:CD012992
pubmed: 34905228
J Trauma. 2008 Mar;64(3):561-70; discussion 570-1
pubmed: 18332794
Gastroenterol Rep (Oxf). 2016 May;4(2):165-7
pubmed: 25381204
Cardiovasc Intervent Radiol. 2021 Nov;44(11):1709-1719
pubmed: 34173045
Dis Esophagus. 2011 Nov;24(8):E36-40
pubmed: 21883655
J Trauma Acute Care Surg. 2015 Feb;78(2):360-9
pubmed: 25757123
Heart. 2001 Apr;85(4):365-8
pubmed: 11250953
J Card Surg. 2013 Sep;28(5):561-3
pubmed: 23889586
Ann Surg. 2022 Nov 1;276(5):e598-e604
pubmed: 33214448
Ann Vasc Surg. 2019 Nov;61:142-147
pubmed: 31394222
J Vasc Surg. 2020 Jan;71(1):270-282
pubmed: 31327611
Vascular. 2010 Sep-Oct;18(5):250-5
pubmed: 20822718
J Vasc Surg. 2014 Jan;59(1):248-54
pubmed: 24199764
Eur J Vasc Endovasc Surg. 2010 Mar;39(3):273-9
pubmed: 20096612
Ann Vasc Surg. 2019 Feb;55:157-165
pubmed: 30217710
Surg Today. 2020 Dec;50(12):1551-1559
pubmed: 31844987
Ann Vasc Surg. 2012 May;26(4):454-61
pubmed: 22285374
Br J Surg. 2014 Sep;101(10):1244-51
pubmed: 25048981
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
J Vasc Surg. 2010 Apr;51(4):1026-32, 1032.e1-1032.e2
pubmed: 20347700
Eur J Cardiothorac Surg. 2014 Mar;45(3):452-7
pubmed: 23904131
Ann Vasc Surg. 2021 Apr;72:419-429
pubmed: 33227472
N Engl J Med. 1994 Dec 29;331(26):1729-34
pubmed: 7984192
J Card Surg. 2021 Oct;36(10):3820-3830
pubmed: 34310731
J Vasc Surg. 2011 Jan;53(1):193-199.e1-21
pubmed: 21035988
Vascular. 2018 Feb;26(1):39-46
pubmed: 28699426
World J Surg. 2018 May;42(5):1551-1558
pubmed: 29167953
Grudn Khir. 1988 Nov-Dec;(6):84-6
pubmed: 3220297
J Vasc Surg. 2021 Mar;73(3):896-902
pubmed: 32682070
Eur J Cardiothorac Surg. 2015 Feb;47(2):374-82; discussion 382-3
pubmed: 24743003
World J Surg. 1996 Jul-Aug;20(6):655-63
pubmed: 8662149
J Vasc Surg. 2010 Jul;52(1):39-44
pubmed: 20494542
J Vasc Surg Cases Innov Tech. 2021 Apr 24;7(3):396-398
pubmed: 34278067